I. Hume

发表

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.

J. Kopecek, J. Kopeček, R. Duncan, 1987, British Journal of Cancer.

BIOLOGICAL PROPERTIES OF ADRIAMYCIN BOUND TO BIODEGRADABLE POLYMERIC CARRIERS

J. Feijen, R. Duncan, J. Bouma, 1993 .

Polymer-bound derivatives of sarcolysin and their antitumour activity against mouse and human leukaemia in vitro

K. Ulbrich, J. Kopeček, R. Duncan, 1987 .

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

J. Kopeček, R. Duncan, J. Lloyd, 1988, British Journal of Cancer.

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo

K. Ulbrich, J. Kopeček, R. Duncan, 1989 .

Effect of galactose on interaction of N‐(2‐hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: Preliminary application to an anticancer agent, daunomycin

L. Scarlett, J. Kopeček, R. Duncan, 1989, Hepatology.

Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymers

K. Ulbrich, V. Šubr, R. Duncan, 1991 .

Preclinical evaluation of polymer-bound doxorubicin

K. Ulbrich, V. Šubr, S. Wedge, 1992 .

Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo

K. Ulbrich, V. Šubr, R. Duncan, 1992 .

N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.

K. Ulbrich, S. Wedge, R. Duncan, 1991, British Journal of Cancer.